The Harvard Catalyst Reliance Agreement supports institutions and investigators who propose multicenter studies. The goal of the agreement is to reduce duplicative IRB review.
In order to utilize the Harvard Catalyst Reliance Agreement for IRB review, both the ceding and assuming IRB must have signed on to the Master Reciprocal Common IRB Reliance Agreement. Tufts has signed on to the Harvard Catalyst Reliance Agreement. To find out if the institution you are collaborating with has signed this agreement, refer to the Harvard Catalyst website: https://catalyst.harvard.edu/programs/regulatory/reliance.html#sign.
In order for one IRB to assume (take on) oversight and the other IRB to cede (give up) oversight for a study under the Harvard Catalyst Reliance Agreement, you need to confirm the site you are working with is agreeable to this plan and you need to obtain approval from Tufts by submitting a request to the Tufts IRB.
To submit a request for Tufts Health Sciences IRB to cede or assume IRB oversight of your research study through the Harvard Catalyst Reliance Agreement, please submit the following: